With the phase 1/2 study due for completion this month, lets hope for some positive preliminary results this year. Pr-clinical trials showed incredible potential, for my mind IMM-529 is the one to watch. Sellers are drying up on the ASX, the market seems poised for news, with additional trial results due early to mid next year we may be within 6-12 months of seeing a reward for our continued patience.
For an interesting read see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027166/
Apologies if someone has posted previously.
Treatment for Clostridium-difficile Infection With IMM529
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
